Cargando…
Voice-based screening for SARS-CoV-2 exposure in cardiovascular clinics
AIMS: Artificial intelligence (A.I) driven voice-based assistants may facilitate data capture in clinical care and trials; however, the feasibility and accuracy of using such devices in a healthcare environment are unknown. We explored the feasibility of using the Amazon Alexa (‘Alexa’) A.I. voice-a...
Autores principales: | Sharma, Abhinav, Oulousian, Emily, Ni, Jiayi, Lopes, Renato, Cheng, Matthew Pellan, Label, Julie, Henriques, Filipe, Lighter, Claudia, Giannetti, Nadia, Avram, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344943/ https://www.ncbi.nlm.nih.gov/pubmed/36713601 http://dx.doi.org/10.1093/ehjdh/ztab055 |
Ejemplares similares
-
Attitudes About Artificially Intelligent Interactive Voice Response Systems Using Amazon Alexa in Cardiovascular Clinics: Insights from the VOICE-COVID-19 Study
por: Ganni, Elie, et al.
Publicado: (2023) -
Voice-assisted Artificial Intelligence-enabled Screening for Severe Acute Respiratory Syndrome Coronavirus 2 Exposure in Cardiovascular Clinics: Primary Results of the VOICE-COVID-19-II Randomized Trial
por: Sharma, ABHINAV, et al.
Publicado: (2023) -
Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial
por: Oulousian, Emily, et al.
Publicado: (2023) -
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical Trials
por: Gouda, Pishoy, et al.
Publicado: (2021) -
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial
por: Aflaki, Mona, et al.
Publicado: (2021)